BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 2061799)

  • 1. The changing incidence of neural tube defects in Scotland.
    Davis CF; Young DG
    J Pediatr Surg; 1991 May; 26(5):516-8. PubMed ID: 2061799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in neural tube defects 1980-1989.
    Bower C; Raymond M; Lumley J; Bury G
    Med J Aust; 1993 Feb; 158(3):152-4. PubMed ID: 8450777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of neural tube defects in South Australia, 1966-91: effectiveness and impact of prenatal diagnosis.
    Chan A; Robertson EF; Haan EA; Keane RJ; Ranieri E; Carney A
    BMJ; 1993 Sep; 307(6906):703-6. PubMed ID: 8401091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal screening and diagnosis of neural tube defects in England and Wales in 1985.
    Cuckle HS; Wald NJ; Cuckle PM
    Prenat Diagn; 1989 Jun; 9(6):393-400. PubMed ID: 2668917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Occurrence of cleft defects of the central nervous system in the Czech Republic 1961-1999. Incidence, prenatal diagnosis and prevalence based on maternal age].
    Sípek A; Horácek J; Gregor V; Rychtaríková J; Dzúrová D; Masátová D
    Ceska Gynekol; 2000 Dec; 65 Suppl 1():7-13. PubMed ID: 11394235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High burden of neural tube defects in Tigray, Northern Ethiopia: Hospital-based study.
    Berihu BA; Welderufael AL; Berhe Y; Magana T; Mulugeta A; Asfaw S; Gebreselassie K
    PLoS One; 2018; 13(11):e0206212. PubMed ID: 30427877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The sensitivity of ultrasound and serum alpha-fetoprotein in population-based antenatal screening for neural tube defects. South Australia 1986-1991.
    Chan A; Robertson EF; Haan EA; Ranieri E; Keane RJ
    Br J Obstet Gynaecol; 1995 May; 102(5):370-6. PubMed ID: 7542023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The changing epidemiology of neural tube defects. United States, 1968-1989.
    Yen IH; Khoury MJ; Erickson JD; James LM; Waters GD; Berry RJ
    Am J Dis Child; 1992 Jul; 146(7):857-61. PubMed ID: 1496959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Weekly administration of folic acid and epidemiology of neural tube defects.
    Martínez de Villarreal LE; Arredondo P; Hernández R; Villarreal JZ
    Matern Child Health J; 2006 Sep; 10(5):397-401. PubMed ID: 16900407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Chief Scientist reports.... Pattern of decline in prevalence of anencephaly and spina bifida in a high risk area.
    Omran M; Stone DH; McLoone P
    Health Bull (Edinb); 1992 Sep; 50(5):407-13. PubMed ID: 1399588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spina bifida--a vanishing nightmare?
    Lorber J; Ward AM
    Arch Dis Child; 1985 Nov; 60(11):1086-91. PubMed ID: 3907511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the prevalence of spina bifida and encephalocele in a Kenyan hospital from 2005-2010: implications for a neural tube defects surveillance system.
    Githuku JN; Azofeifa A; Valencia D; Ao T; Hamner H; Amwayi S; Gura Z; Omolo J; Albright L; Guo J; Arvelo W
    Pan Afr Med J; 2014; 18():60. PubMed ID: 26113894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extremely high prevalence of neural tube defects in a 4-county area in Shanxi Province, China.
    Li Z; Ren A; Zhang L; Ye R; Li S; Zheng J; Hong S; Wang T; Li Z
    Birth Defects Res A Clin Mol Teratol; 2006 Apr; 76(4):237-40. PubMed ID: 16575897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High potential for reducing folic acid-preventable spina bifida and anencephaly, and related stillbirth and child mortality, in Ethiopia.
    Dixon M; Kancherla V; Magana T; Mulugeta A; Oakley GP
    Birth Defects Res; 2019 Nov; 111(19):1513-1519. PubMed ID: 31424635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antecedent circumstances surrounding neural tube defect births in 1990-1991. The Steering Committee of the National Confidential Enquiry into Counselling for Genetic Disorders.
    Williamson P; Alberman E; Rodeck C; Fiddler M; Church S; Harris R
    Br J Obstet Gynaecol; 1997 Jan; 104(1):51-6. PubMed ID: 8988697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of screening for open neural tube defects in England and Wales.
    Cuckle H; Wald N
    Prenat Diagn; 1987 Feb; 7(2):91-9. PubMed ID: 2437555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for congenital neural tube defects in a high-risk area: an epidemiological perspective.
    Stone DH; Smalls MJ; Rosenberg K; Womersley J
    J Epidemiol Community Health; 1988 Sep; 42(3):271-3. PubMed ID: 3074990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of neural tube defects in Afyonkarahisar, Western Turkey.
    Onrat ST; Seyman H; Konuk M
    Genet Mol Res; 2009 Feb; 8(1):154-61. PubMed ID: 19283682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of maternal serum alpha fetoprotein screening on open neural tube defect births in north-east Scotland.
    Thom H; Campbell AG; Farr V; Fisher PM; Hall MH; Swapp GH; Gray ES
    Prenat Diagn; 1985; 5(1):15-9. PubMed ID: 2579374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An epidemiologic study of neural tube defects: Delta County, Michigan, 1969-1988.
    Brazeau NK; Wentz SJ; Hansen AM; Holmes TM
    Fam Pract Res J; 1992 Jun; 12(2):205-12. PubMed ID: 1621541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.